WhiteHorse Finance, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WhiteHorse Finance, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.34M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $10.85M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $20.41M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $15.68M | Jun 10, 2025 |
| FY2023 | Dec 31, 2021 | $30.09M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $31.69M | Mar 3, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.27M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $78.76M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $90.37M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $71.99M | Jun 10, 2025 |
| FY2023 | Dec 31, 2021 | ($90.19M) | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | ($64.60M) | Mar 3, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $615.13M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $676.82M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $730.75M | Jun 10, 2025 |
| FY2023 | Dec 31, 2022 | $796.47M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $851.02M | Mar 3, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $355.34M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $390.69M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $413.98M | Jun 10, 2025 |
| FY2023 | Dec 31, 2022 | $464.09M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $501.27M | Mar 3, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $259.79M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $286.13M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $316.77M | Jun 10, 2025 |
| FY2023 | Dec 31, 2022 | $332.39M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $349.75M | Mar 3, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($69.35M) | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | ($51.09M) | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | ($21.53M) | Jun 10, 2025 |
| FY2023 | Dec 31, 2022 | ($6.88M) | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $10.57M | Mar 3, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.03M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $12.42M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $10.75M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $9.51M | Jun 10, 2025 |
| FY2023 | Dec 31, 2021 | $12.19M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $8.06M | Mar 3, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $323.83M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $353.12M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $386.45M | Jun 10, 2025 |
| FY2023 | Dec 31, 2022 | $440.43M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $475.96M | Mar 3, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Jun 10, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 3, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Jun 10, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 3, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22.23M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 23.24M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | 23.24M | Mar 6, 2026 |
| FY2025 | Dec 31, 2022 | 23.24M | Mar 6, 2026 |
| FY2025 | Dec 31, 2021 | 23.16M | Mar 6, 2026 |
| FY2024 | Dec 31, 2020 | 20.55M | Jun 10, 2025 |
| FY2023 | Dec 31, 2019 | 20.55M | Mar 5, 2024 |
| FY2022 | Dec 31, 2018 | 20.55M | Mar 3, 2023 |